An interventional study of Early warning system monitoring. and routine care in Congestive Heart Failure, Chronic Obstructive Pulmonary Disease and Cancer, sponsored by Washington University School of Medicine. Completed at 1 site in United States. Open to participants aged 18 Years to 100 Years. Per ClinicalTrials.gov, last updated 2022-05-11.
Sponsored by Washington University School of Medicine · Not applicable, Interventional, and Prevention
The study will begin in 2013 whereby patients having an early warning system (EWS) alert will be randomized to be seen by the rapid response team (RRT) for triage versus usual care. A RRT is usually made up of a nurse and/or a physician who respond to a requested activation of the RRT (called an "ACT"). The intervention will occur as follows:
The study will begin in 2013 whereby patients having an early warning system (EWS) alert will be randomized to be seen by the rapid response team (RRT) for triage versus usual care. A RRT is usually made up of a nurse and/or a physician who respond to a requested activation of the RRT (called an "ACT"). The intervention will occur as follows:
2,592 studies on the registry are indexed under Lung Diseases, Obstructive; 198 are open to participants now.
This study's enrollment of 571 is above the median of 66 across 1,837 interventional studies indexed under Lung Diseases, Obstructive.
Browse Lung Diseases, Obstructive studies →Washington University School of Medicine is the lead sponsor of 1,765 studies on the registry; 271 are open to participants now.
Of its 324 completed or terminated interventional studies of FDA-regulated products, 212 (65%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
General hospital ward patients will receive routine care.
Other: routine care
The intervention with early warning system monitoring is to have the rapid response team assess the patients real-time.
Other: Early warning system monitoring.
General hospital ward patients will be monitored 24/7 for clinical deterioration using the early warning system monitoring developed at Washington University.
ICU Transfer
Patients transferred to the ICU from a general hospital ward will be assessed as having met the outcome.
Time frame: Patients will be assessed for the primary outcome measure during their hospital with an average of 14 days.
Mortality
Death during hospitalization will be used to determine the presence of this outcome.
Time frame: Patients will be asessed for the secondary outcome measure during an average of 28 days..
| Milestone | Routine Care | Intervention Arm |
|---|---|---|
| Started | 285 | 286 |
| Completed | 285 | 286 |
| Not completed | 0 | 0 |
Patients transferred to the ICU from a general hospital ward will be assessed as having met the outcome.
| participants | Routine Care | Intervention Arm |
|---|---|---|
| ICU Transfer | 52 | 51 |
Death during hospitalization will be used to determine the presence of this outcome.
Results for this outcome have not been posted.
Non-serious events are listed at a 0% frequency threshold.
| Group | Deaths | Serious | Other |
|---|---|---|---|
| Routine Care | — | 0/285 (0%) | 0/285 (0%) |
| Intervention Arm | — | 0/286 (0%) | 0/286 (0%) |
| Age, Continuous(years) | Routine Care | Intervention Arm | Total |
|---|---|---|---|
| Mean | 63.1 ± 15.4 | 63.7 ± 16 | 63.3 ± 15.5 |
| Sex: Female, Male(Participants) | Routine Care | Intervention Arm | Total |
|---|---|---|---|
| Female | 140 | 132 | 272 |
| Male | 145 | 154 | 299 |
| Region of Enrollment(participants) | Routine Care | Intervention Arm | Total |
|---|---|---|---|
| United States | 285 | 286 | 571 |
This study is completed, as verified in Apr 2022. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Washington University School of Medicine